A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer.
Shunji TakahashiMunetaka TakekumaKenji TamuraKazuhiro TakeharaHiroyuki NomuraMakiko OnoMayu YunokawaDaisuke AokiPublished in: International journal of clinical oncology (2021)
JapicCTI-163164.